Access to Medicines
Anna Eshoo Biosimilars (HR1548) bill has bad provisions on data exclusivity
Submitted by James Love on 16. July 2009 - 12:00Congress should reject the 12-14.5 year monopoly for biologic products provided for in HR 1548
KEI* opposes H.R.1548, the bill to “establish a pathway for the licensure of biosimilar biological products,” on the grounds that the period of the monopoly is excessive, and not subject to safeguards that would protect consumers.
Margaret Chan on “new initiatives, and new incentive schemes”
Submitted by thiru on 13. July 2009 - 22:00At the WIPO Conference on Intellectual Property and Public Policy Issues today, Margaret Chan, the Director General of the World Health Organization, made the following speech at WIPO’s Conference on Intellectual Property and Public Policy Issues on the topic of “Strengthening Multilateral Cooperation on IP and Public Health” where she shared the limelight with Pascal Lamy, Director General of the World Trade Organ
Indian Minister of State for External Affairs broaches seizures of generics at ECOSOC
Submitted by thiru on 7. July 2009 - 22:00Note: Only a portion of the speech is reproduced here.
Special Event on Africa and the Least Developed Countries:
Partnerships and Health
(1130 – 1330 hrs, 8 July 2009, Geneva
Intervention by Hono’ble Minister of State for External Affairs, Smt. Preneet Kaur
Hon’ble Co-Chairs/Madam Moderator, Distinguished Delegates,
Pope Benedict XVI encyclical letter denounces excessive zeal for assertions of intellectual property rights in knowledge
Submitted by Staff on 6. July 2009 - 22:00Pope Benedict XVI today issued a statement saying that “On the part of rich countries, there is excessive zeal for protecting knowledge through an unduly rigid assertion of the right to intellectual property, especially in the field of health care.” The criticism came in a section of his most recent encyclical letter dealing with social issues, and specifically focusing on international human development and systemic failures of bodies large and small to solve development problems.
WHO releases sketchy report on second meeting of Expert Working Group on R&D Financing
Submitted by Staff on 30. June 2009 - 22:00The World Health Organization just published a report on this week’s second meeting of the WHO Expert Working Group (EWG) on R&D Financing.
Press Advisory: NGO letters to WHO & WTO on Dutch seizures of generic medicines in-transit from India to Brazil, Colombia & Peru
Submitted by thiru on 19. February 2009 - 5:32February 19, 2009
Press Advisory on NGO letters to WHO and WTO on topic of Dutch seizures of generic medicines in-transit from India to Brazil, Colombia and Peru.
In response to news about four seizures of generic medicines manufactured in India and shipped through the Netherlands in route to Brazil, Colombia and Peru, sixteen public health, consumer and development NGOs have sent separate letters to the heads of the World Health Organization (WHO) and the World Trade Organization (WTO).
FTC Alleges Price Gouging, Monopoly For Baby Medicines
Submitted by James Love on 17. December 2008 - 9:10This was the title the Washington Post today gave the AP story.
This was the title of the FTC Press release:
Unbranding Medicines — Harvard workshop on generics
Submitted by James Love on 12. December 2008 - 3:04Today I am at Harvard, attending a workshop titled: Unbranding Medicines: the politics, promise, and challenge of generic drugs. This is put on by the Harvard Interfaculty Initiative on Medicines and Society. The program in general is quite impressive, particularly as regards to the depth of experience and knowledge about the generic drug industry, including its early origins.
I was asked to speak about the use of prizes. The slides from my presentation are here:
Collective Management of IPR & Patent Pools
KEI has been researching and advocating for the collective management of Intellectual Property Rights and the use of patent pools to promote both new innovation and access to medicines.
Misc notes on Compulsory Licensing of Patents
Worth reading first
March 8, 2007, Recent examples of the use of compulsory licensing of patents, revised March 31, 2007.
Misc
June 9, 2007. When customs authorities may allow infringing goods to be imported into the United States.